UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Preclinical Amyloid-beta and Axonal Degeneration Pathology in Delirium

Idland, A-V; Wyller, TB; Stoen, R; Eri, LM; Frihagen, F; Raeder, J; Chaudhry, FA; ... Watne, LO; + view all (2017) Preclinical Amyloid-beta and Axonal Degeneration Pathology in Delirium. Journal of Alzheimer's Disease , 55 (1) pp. 371-379. 10.3233/JAD-160461. Green open access

[thumbnail of Idland_Preclinical_Amyloid-beta_Axonal.pdf]
Preview
Text
Idland_Preclinical_Amyloid-beta_Axonal.pdf - Accepted Version

Download (168kB) | Preview

Abstract

BACKGROUND: The clinical relevance of brain β-amyloidosis in older adults without dementia is not established. As delirium and dementia are strongly related, studies on patients with delirium may give pathophysiological clues. OBJECTIVE: To determine whether the Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarkers amyloid-β 1-42 (Aβ42), total tau (T-tau), and phosphorylated tau (P-tau) are associated with delirium in hip fracture patients with and without dementia. METHODS: CSF was collected in conjunction to spinal anesthesia in 129 patients. Delirium was assessed using the Confusion Assessment Method once daily in all patients, both pre- and postoperatively. The diagnosis of dementia at admission was based upon clinical consensus. CSF levels of Aβ42, T-tau, and P-tau were analyzed. RESULTS: In patients without dementia, we found lower CSF Aβ42 levels (median, 310 ng/L versus 489 ng/L, p = 0.006), higher T-tau levels (median, 505 ng/L versus 351 ng/L, p = 0.02), but no change in P-tau in patients who developed delirium (n = 16) compared to those who remained lucid (n = 49). Delirious patients also had lower ratios of Aβ42 to T-tau (p < 0.001) and P-tau (p = 0.001) relative to those without delirium. CSF Aβ42 and T-tau remained significantly associated with delirium status in adjusted analyses. In patients with dementia, CSF biomarker levels did not differ between those with (n = 54) and without delirium (n = 10). CONCLUSION: The reduction in CSF Aβ42, indicating β-amyloidosis, and increase in T-tau, indicating neurodegeneration, in hip fracture patients without dementia developing delirium indicates that preclinical AD brain pathology is clinically relevant and possibly plays a role in delirium pathophysiology.

Type: Article
Title: Preclinical Amyloid-beta and Axonal Degeneration Pathology in Delirium
Open access status: An open access version is available from UCL Discovery
DOI: 10.3233/JAD-160461
Publisher version: http://dx.doi.org/10.3233/JAD-160461
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Alzheimer’s disease, biomarkers, cerebrospinal fluid, delirium, dementia, physiopathology
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI: https://discovery.ucl.ac.uk/id/eprint/1537969
Downloads since deposit
139Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item